RecruitingNCT03416959
Bone Metastases Database of Patients Treated Surgically for Impending or Pathologic Fracture of Long Bones
Prospective Bone Metastases Database
Sponsor
Istituto Ortopedico Rizzoli
Enrollment
120 participants
Start Date
Jan 1, 2018
Study Type
OBSERVATIONAL
Conditions
Summary
The aims of this study are to collect prospective data on the natural history of bone metastases (BMs) and skeleta related events (SREs),
Eligibility
Inclusion Criteria1
- Patients with long bone metastases treated surgically with intramedullary nail or endoprosthetic reconstruction
Exclusion Criteria1
- Patients with bone metastases of the spine
Interested in this trial?
Get notified about updates and connect with the research team.
Interventions
PROCEDUREintramedullary fixation or endoprosthetic reconstruction
Surgical treatment for long bone metastases with intramedullary nail or endoprosthetic reconstruction
Locations(1)
View Full Details on ClinicalTrials.gov
For the most up-to-date information, visit the official listing.
NCT03416959
Related Trials
A Three-Part Phase 3 Study of Sofetabart Mipitecan in Participants With Platinum-Resistant (Part A) and Platinum-Sensitive (Parts B and C) Ovarian Cancer
NCT07213804261 locations
PROVIDENCE - Prospective Non-interventional Study (NIS) to Examine Patient-reported Outcomes and Real-world Clinical Data in Patients With HER2-positive, HER2-low or HER2-ultralow Unresectable or Metastatic Breast Cancer Treated With Trastuzumab Deruxtecan
NCT05573893107 locations
A Study of 2nd-line FOLFIRI ± Bevacizumab vs. Irinotecan ± Bevacizumab in mCRC
NCT033034951 location
A Study of Tersolisib (LY4064809/STX-478) With Other Anti-Cancer Treatments in Participants With Advanced Breast Cancer With a Genetic Change (PIK3CA)
NCT07174336327 locations
A Study of LY4257496 in Participants With Cancer (OMNIRAY)
NCT0711460130 locations